Pivacain-L Injection

About Pivacain-L 2.5 mg/ml Injection

Pivacain-L is a 2.5 mg/ml injection containing levobupivacaine hydrochloride, a long-acting local anaesthetic of the amide type. It is given by a healthcare professional to produce local or regional anaesthesia and to help manage pain after surgery.

There are 3 brands of Levobupivacaine Hydrochloride listed in Bangladesh.

What is Pivacain-L 2.5 mg/ml Injection?

Pivacain-L 2.5 mg/ml injection is a regional anaesthetic containing levobupivacaine hydrochloride. It works by blocking nerve conduction in sensory and motor nerves, mainly by interacting with voltage-sensitive sodium channels on the cell membrane. It is used to produce local or regional anaesthesia for surgery and obstetrics, and for post-operative pain management. It is given as the hydrochloride for infiltration anaesthesia and regional nerve blocks, including epidural block. The medicine is administered only by a qualified healthcare professional in a setting where resuscitation equipment is available. The doctor decides the dose and course for each patient.

Uses of Pivacain-L

Pivacain-L 2.5 mg/ml injection is used to produce local or regional anaesthesia for surgery and obstetrics, and for post-operative pain management. It is a long-acting local anaesthetic of the amide type, given as the hydrochloride for infiltration anaesthesia and regional nerve blocks, including epidural block. It is not for use in intravenous regional anaesthesia (Bier's block) or in paracervical block in obstetrics. The doctor decides whether this medicine is suitable for a particular procedure.

How to use Pivacain-L

Pivacain-L 2.5 mg/ml injection is given by a healthcare professional, usually as an infiltration or regional nerve block, including epidural block. It is not for intravenous regional anaesthesia (Bier's block) or paracervical block in obstetrics. The doctor decides the dose and course, taking into account the procedure, the patient's condition and other factors. The injection is prepared and given in a setting where resuscitative equipment is available. Patients should follow the instructions given by their doctor and care team.

Side effects of Pivacain-L

Side effects of Pivacain-L 2.5 mg/ml injection can include central nervous system effects such as restlessness, anxiety, dizziness, confusion, respiratory depression and convulsions. Neuromuscular and skeletal weakness, blurred vision, pupillary constriction and tinnitus may occur. Hypotension, bradycardia and cardiovascular collapse, which may lead to cardiac arrest, have been reported. Rarely, hypersensitivity reactions may occur. Patients should tell their doctor or care team about any unusual symptoms; the doctor will decide on further management.

Safety and precautions

Pivacain-L 2.5 mg/ml injection should be used only by a healthcare professional. Tell the doctor about epilepsy, respiratory impairment, impaired cardiac conduction, bradycardia, severe shock, acute porphyria, myasthenia gravis, or kidney or liver problems. It is not to be used in intravenous regional anaesthesia (Bier's block) or paracervical block in obstetrics, and it should not be used in hypovolaemia or complete heart block. Pregnancy category B; discuss pregnancy and breastfeeding with the doctor. The dose is reduced in elderly or debilitated patients. Resuscitative equipment should be available.

Frequently asked questions

How is Pivacain-L 2.5 mg/ml injection given?

It is given by a healthcare professional as an infiltration or regional nerve block, including epidural block. It is not for intravenous regional anaesthesia (Bier's block) or paracervical block in obstetrics. The doctor decides the dose and course, and the injection is given where resuscitative equipment is available.

What is Pivacain-L 2.5 mg/ml injection used for and what kind of medicine is it?

It is a long-acting local anaesthetic of the amide type. It is used to produce local or regional anaesthesia for surgery and obstetrics, and for post-operative pain management. It is given as the hydrochloride for infiltration anaesthesia and regional nerve blocks, including epidural block. The doctor decides if it is suitable for a procedure.

What side effects should I watch for and when should I call the doctor?

Watch for restlessness, anxiety, dizziness, confusion, breathing problems, convulsions, weakness, blurred vision, ringing in the ears, low blood pressure, slow heart rate, or signs of an allergic reaction. Because this injection is given by a healthcare professional, tell your care team immediately if you notice any unusual symptoms.

What should I tell the doctor before receiving Pivacain-L 2.5 mg/ml injection?

Tell the doctor about epilepsy, breathing problems, heart conduction problems, slow heart rate, severe shock, acute porphyria, myasthenia gravis, kidney or liver problems, pregnancy, or breastfeeding. Also mention any medicines you take, including enzyme-inducing drugs such as rifampicin, because interactions can occur. The doctor will decide if the injection is suitable.

Indications

For the production of local or regional anesthesia for surgery and obstetrics, and for post-operative pain management

Pharmacology

Levobupivacaine is a long acting local anaesthetic of the amide type. It is the S-enantiomer of bupivacaine. It blocks nerve conduction in sensory and motor nerves mainly by interacting with voltage sensitive sodium channels on the cell membrane. It also interferes with impulse transmission and conduction in other tissues. Levobupivacaine is given as the hydrochloride for infiltration anaesthesia and regional nerve blocks including epidural block. It is contraindicated in obstetric paracervical block and IV regional anaesthesia (Bier's block). The 0.75% solution is also contraindicated for epidural blocks in obstetrics.

Dosage & Administration

Acute pain: Pain relief during labour: 15-50 mg (6-20 ml) of a 0.25% solution, to be given as a bolus dose; alternatively, dose may be given via continuous infusion at 5-12.5 mg (4-10 ml) per hr using 0.125% solution or 5-12.5 mg (8-20 ml) per hr using 0.0625% solution.

Postoperative pain: 10-25 mg (4-10 ml) per hr of a 0.25% solution, 12.5-18.75 mg (10-15 ml) per hr of a 0.125% solution or 12.5-18.75 mg (20-30 ml) per hr of a 0.0625% solution; dose may be given as an epidural infusion. Max: 150 mg/dose; 400 mg/day.

Peripheral nerve block: 2.5-150 mg or 1-2 mg/kg (0.4 ml/kg) of a 0.25 or 0.5% solution. Not to exceed 40 ml. Max: 150 mg/dose; 400 mg/day.

Surgical anaesthesia: Epidural block: 50-100 mg (10-20 ml) of a 0.5% solution or 75-150 mg (10-20 ml) of a 0.75% solution. Caesarean section: 75-150 mg (15-30 ml) of a 0.5% solution. Spinal block: 15 mg (3 ml) of a 0.5% solution. Max: 150 mg/dose; 400 mg/day.

Infiltration anaesthesia:
  • Adult: Up to 150 mg (60 ml) of a 0.25% solution. For peribulbar block in ophth procedures: 37.5-112.5 mg (5-15 ml) of a 0.75% solution. Max: 150 mg/dose; 400 mg/day.
  • Child: For ilioinguinal or iliohypogastric blocks in children <12 yr: 0.625-2.5 mg/kg (0.25-0.5 ml/kg) of a 0.25 or 0.5% solution.

Interaction

Plasma levels may be reduced when used with enzyme-inducing drugs such as rifampicin. Substrates for or inhibitors of CYP3A4 and CYP1A2 may affect the plasma levels of levobupivacaine.

Contraindications

Not to be used in IV regional anesth (Bier's block) and paracervical block in obstetrics. Do not use 0.75% solution for epidural block in obstetrics. Hypovolaemia, complete heart block.

Side Effects

CNS effects such as restlessness, anxiety, dizziness, confusion, respiratory depression and convulsions. Neuromuscular and skeletal weakness, blurred vision, pupillary constriction, tinnitus. Hypotension, bradycardia and CV collapse which may lead to cardiac arrest. Rarely, hypersensitivity reactions.

Pregnancy & Lactation

Pregnancy Category B. Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).

Precautions & Warnings

Epilepsy, respiratory impairment, impaired cardiac conduction, bradycardia, severe shock, acute porphyria, myasthenia gravis, renal or hepatic impairment. Pregnancy, lactation. Reduce dose in elderly or debilitated patients. Resuscitative equipment should be available. Do not use solutions containing adrenaline for anesth in appendages. Do not use solutions containing preservatives for caudal or epidural block.

Storage Conditions

To be used immediately after opening. After dilution in normal saline: Chemical and physical in-use stability at 20-22°C for 7 days.

Alternative brands of Levobupivacaine Hydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.